BioMarin Pharmaceutical Inc. (BVMF:B1MR34)
Brazil
· Delayed Price · Currency is BRL 143.56
+1.73 (1.22%)
At close: Dec 5, 2025
Revenue
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2013 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2013 - 2020 |
| VOXZOGO Revenue | 862.03M | 735.09M |
Log In |
Log In |
Log In | Upgrade
|
| VIMIZIM Revenue | 777.62M | 739.78M |
Log In |
Log In |
Log In | Upgrade
|
| NAGLAZYME Revenue | 475.18M | 479.58M |
Log In |
Log In |
Log In | Upgrade
|
| PALYNZIQ Revenue | 408.40M | 355.05M |
Log In |
Log In |
Log In | Upgrade
|
| ALDURAZYME Revenue | 198.16M | 183.89M |
Log In |
Log In |
Log In | Upgrade
|
| BRINEURA Revenue | 184.73M | 169.08M |
Log In |
Log In |
Log In | Upgrade
|
| KUVAN Revenue | 104.52M | 120.90M |
Log In |
Log In |
Log In | Upgrade
|
| ROCTAVIAN Revenue | 33.44M | 26.07M |
Log In |
Log In |
Log In | Upgrade
|
| Total Net Product Revenue | 3.04B | 2.81B |
Log In |
Log In |
Log In | Upgrade
|
| Royalty and Other Revenue | 49.93M | 44.47M |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Other) | -33.44M | -26.07M |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Total) | 3.09B | 2.85B |
Log In |
Log In |
Log In | Upgrade
|
| Royalty and Other Revenue | 49.93M | 44.47M |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2013 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2013 - 2020 |
| Royalty and Other Revenue | 49.93M | 44.47M |
Log In |
Log In |
Log In | Upgrade
|
| Royalty and Other Revenue | 49.93M | 44.47M |
Log In |
Log In |
Log In | Upgrade
|
| United States Revenue | 1.06B | 924.81M |
Log In |
Log In |
Log In | Upgrade
|
| Europe Revenue | 889.18M | 829.03M |
Log In |
Log In |
Log In | Upgrade
|
| Latin America Revenue | 387.18M | 378.08M |
Log In |
Log In |
Log In | Upgrade
|
| Rest of World Revenue (Pre-Q3 2024) | - | - |
Log In |
Log In |
Log In | Upgrade
|
| Rest of World Revenue (Post-Q2 2024) | 512.34M | 493.63M |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Other) | 198.16M | 183.89M |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Total) | 3.09B | 2.85B |
Log In |
Log In |
Log In | Upgrade
|